June 28 – 30, 2023 | Boston, MA

Returning for 2023, North America’s definitive microbiome drug development event is back bigger and better than ever!

With three days of expert-led sessions and interactive discussions on microbial-based approaches, biomarkers, and host-microbe relationships. Plus 80+ speakers covering everything from metabolic pathways to clinical endpoints and diagnostic settings, you’ll gain valuable insights into combination therapies, smart clinical trial data, and GMP-compliant manufacturing. Choose from three tracks and explore innovative content such as leveraging fungal and viral components, bacterial engineering, medical foods, and securing capital to scale your business.

Helping to leverage this evolving landscape, Beacon’s own lead microbiome research analyst, Costanza Gorini, joins an expert-speaking faculty to discuss the preclinical landscape, including current and future opportunities for development and investment. Make sure to catch her at 4:30 pm on Day 1 or with the rest of the team at the Beacon booth throughout the conference!

Don’t miss this opportunity to move the needle forward, launch ground-breaking therapies into the market and be part of this exciting time in microbiome drug development!